Celebrating a year of ASH Scholar awardees. [PDF]
Blood AdvBollard CM, Weyrich AS.
europepmc +1 more source
Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers [PDF]
, 2015 core +1 more source
Iptacopan in C5 blockade refractory atypical hemolytic uremic syndrome with associated Castleman's disease: case report. [PDF]
BMC NephrolNguyen MD +10 more
europepmc +1 more source
A survey of new oncology drug approvals in the USA from 2010 to 2015: a focus on optimal dose and related postmarketing activities [PDF]
, 2016 Amita Joshi +8 more
core +1 more source
Real-world data of siltuximab for Chinese patients with iMCD: combination with BCD regimen as a potential approach for severe cases. [PDF]
Ann HematolLi SY +10 more
europepmc +1 more source
Evaluation of the reporting quality of randomized controlled trials for treatments in multiple myeloma published the last 5 years using the CONSORT 2010 statment [PDF]
, 2016 Ντέλλας, Παναγιώτης
core +1 more source
Concurrent Idiopathic Multicentric Castleman Disease with TAFRO and Sjögren's Syndrome in a Young Patient: A Challenging Diagnostic Overlap. [PDF]
Eur J Case Rep Intern MedCarvalho MC +3 more
europepmc +1 more source
LRG1, a novel serum biomarker for iMCD disease activity. [PDF]
Biomark ResZhang MY +7 more
europepmc +1 more source